Karo Pharma has entered into an agreement to acquire BioPhausia from Medivir for a cash consideration of SEK## million ($##.## million) on a cash and debt free basis including normalized working capital.
Karo Pharma AB, a healthcare company, has acquired BioPhausia AB from Medivir AB for a cash consideration of approximately SEK## million ($##.## million) through a voluntary share redemption offer open to all shareholders.
Summary
Table of Contents
Search Inside
Marketline's Medivir AB Mergers & Acquisitions, Alliances & Collaborations and Investments analysis includes business overview, comprehensive reports on M&A, divestments, capital raisings, venture capital investments, ownership and partnership deals undertaken by Medivir AB since January2007.
Marketline's Company Mergers & Acquisitions, Alliances & Agreements and Investments reports offer a exhaustive breakdown of the organic and inorganic growth activity undertaken by an institution to sustain its opposing advantage.
This analysis comprises Medivir AB's contact details and business overview, figures&tables, a catalog of partners with their descriptions, contact details, investors and targets, a detailed financial analysis and legal advisors, transactions types, main deals by amount, exhaustive transactions analysis, where disclosed.
This analysis also covers comprehensive financial details for all mergers and acquisitions, private equity, public offering, venture financing, alliances and partnership and other transactions initiated by Medivir AB. These deal reports contain data about target company financials, sources of funding, method of payment, deal prices, and advisors for different parties, where disclosed.
- Offers intelligence on Medivir AB's M&A, important business deals, capital raising and private equity transactions.
- Several analysis of financial deals initiated by Medivir AB and its subsidiaries since 2007.
- Data about top financial and legal advisors for Medivir AB's financial agreements transactions.
-Financial transactions tables and charts encompassing deals by: values, volumes, types and geographical zones.
- Retrieve complete corporate deals data with mergers and acquisition charts and graphs, private equity, and alliances/partnerships and.
- Build an independant judgement about Medivir AB's development strategies through the organic and inorganic actions carried out since 2007.
- Follow your competitors' commercial model and growth plans.
Get Industry Insights. Simply.
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.
Category Manager at
Ikea
ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.
Executive Director at
PwC Advisory
The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!
Scott Griffith
Vice President Marketing at
Maurice Sporting Goods
The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research
Jessica P Huffman
Research Associate at
American Transportation Research Institute
Excellent customer service. Very responsive and fast.
Director, Corporate Strategy at
Ingredion
I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.
Mariana Mendoza
Global Platform Senior Manager at
Whirlpool Corporation
Thanks! I like what you've provided and will certainly come back if I need to do further research works.
Bee Hin Png
CEO at
LDR Pte Ltd
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.
Regeneron Pharmaceuticals, Inc.: Financial Highlights
Regeneron Pharmaceuticals, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Regeneron Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships ...
Siemens Healthcare: Financial Highlights
Siemens Healthcare – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Siemens Healthcare Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...
Arrowhead Research Corporation: Financial Highlights
Arrowhead Research Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Arrowhead Research Corporation Mergers & Acquisitions (M&A), Partnerships ...
Valneva SE: Financial Highlights $ 350 February 2018
Summit Therapeutics Plc: Financial Highlig ... $ 350 February 2018
Gedeon Richter Plc: Financial Highlights $ 350 February 2018
Allergan plc: Financial Highlights $ 350 February 2018
Meda AB: Financial Highlights $ 350 February 2018
Kirin Holdings Company Ltd: Financial High ... $ 350 February 2018
Raptor Pharmaceutical Corp.: Financial Hig ... $ 350 February 2018
More Reports:
Pharmaceutical in the World (6165)
Pharmaceutical in China (428)
Pharmaceutical in Europe (391)
Pharmaceutical in Japan (389)
Molecular Partners AG - Company Report, April 2018
Lung Cancer
Therapy
Oncology
Switzerland
Healthcare Industry - Company Report, April 2018
Brain Cancer
United States
AMAG Pharmaceuticals, Inc. - Analyst Report, April 2018
Therapy
Pharmaceutical
United States
Eisai Co., Ltd. - Analyst Report, April 2018 2 days ago
Indivior PLC - Analyst Report, April 2018 2 days ago
More Reports:
Pharmaceutical in Sweden (177)
Pharmaceutical in the World (2313)
Pharmaceutical in India (1320)
Pharmaceutical in Australia (1229)
Pharmaceutical in Canada (1081)
Pharmaceutical in Europe (937)
Pharmaceutical in China (812)
Country Reports
Sweden
ref:plp2018
Reportlinker.com © Copyright 2018. All rights reserved.